Published in ACS Nano on August 26, 2011
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnology (2014) 1.59
Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnology (2013) 1.57
State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J Control Release (2014) 1.46
Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10. Nanotoxicology (2013) 1.10
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev (2016) 1.08
Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. ACS Nano (2012) 1.07
Comparison of nanotube-protein corona composition in cell culture media. Small (2013) 1.06
Protein corona significantly reduces active targeting yield. Chem Commun (Camb) (2013) 1.05
Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano (2012) 1.04
Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano (2013) 1.03
Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation. Part Fibre Toxicol (2013) 0.98
Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One (2012) 0.95
Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia. Part Fibre Toxicol (2014) 0.91
Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. ACS Nano (2012) 0.90
The nano-plasma interface: Implications of the protein corona. Colloids Surf B Biointerfaces (2014) 0.90
On-chip bioorthogonal chemistry enables immobilization of in situ modified nanoparticles and small molecules for label-free monitoring of protein binding and reaction kinetics. Lab Chip (2012) 0.89
Elucidation of toxicity pathways in lung epithelial cells induced by silicon dioxide nanoparticles. PLoS One (2013) 0.89
Quantitative profiling of the protein coronas that form around nanoparticles. Nat Protoc (2014) 0.89
Exploiting endocytosis for nanomedicines. Cold Spring Harb Perspect Biol (2013) 0.89
Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol (2016) 0.87
Precise quantification of nanoparticle internalization. ACS Nano (2013) 0.85
Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations. PLoS One (2013) 0.85
Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches. Int J Nanomedicine (2015) 0.84
Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine. Antioxidants (Basel) (2016) 0.82
Nanomaterials toxicity and cell death modalities. J Drug Deliv (2012) 0.82
Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes. Sensors (Basel) (2012) 0.82
Nanoparticles: Tracking protein corona over time. Nat Nanotechnol (2013) 0.82
Real-Time Nanoparticle-Cell Interactions in Physiological Media by Atomic Force Microscopy. ACS Sustain Chem Eng (2014) 0.82
Multi-walled carbon nanotube directed gene and protein expression in cultured human aortic endothelial cells is influenced by suspension medium. Toxicology (2012) 0.82
Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. Nanomedicine (2014) 0.81
Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res Lett (2015) 0.81
Graphene-Induced Adsorptive and Optical Artifacts During In Vitro Toxicology Assays. Small (2013) 0.81
Effect of the Protein Corona on Antibody-Antigen Binding in Nanoparticle Sandwich Immunoassays. Bioconjug Chem (2016) 0.79
Adsorption of cellular proteins to polyelectrolyte-functionalized gold nanorods: a mechanism for nanoparticle regulation of cell phenotype? PLoS One (2014) 0.79
Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles - a fluorescence correlation spectroscopy study. Beilstein J Nanotechnol (2014) 0.79
In vitro cytotoxicity of SiO2 or ZnO nanoparticles with different sizes and surface charges on U373MG human glioblastoma cells. Int J Nanomedicine (2014) 0.78
Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo. Int J Nanomedicine (2015) 0.78
Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab (2013) 0.78
Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma. Cell Mol Immunol (2015) 0.78
Spherical nucleic acid nanoparticle conjugates enhance G-quadruplex formation and increase serum protein interactions. Angew Chem Int Ed Engl (2014) 0.78
Vascular Tissue Contractility Changes Following Late Gestational Exposure to Multi-Walled Carbon Nanotubes or their Dispersing Vehicle in Sprague Dawley Rats. J Nanomed Nanotechnol (2014) 0.78
Heterogeneity in nanoparticles influences biodistribution and targeting. Nanomedicine (Lond) (2013) 0.78
Understanding the Kinetics of Protein-Nanoparticle Corona Formation. ACS Nano (2016) 0.77
Electrostatic Interactions and Protein Competition Reveal a Dynamic Surface in Gold Nanoparticle-Protein Adsorption. J Phys Chem C Nanomater Interfaces (2016) 0.77
Analysis of nanoparticle-protein coronas formed in vitro between nanosized welding particles and nasal lavage proteins. Nanotoxicology (2015) 0.77
Relevance of the sterilization-induced effects on the properties of different hydroxyapatite nanoparticles and assessment of the osteoblastic cell response. J R Soc Interface (2012) 0.77
From the Cover: Disease-Induced Disparities in Formation of the Nanoparticle-Biocorona and the Toxicological Consequences. Toxicol Sci (2016) 0.76
Size and surface functionalization of iron oxide nanoparticles influence the composition and dynamic nature of their protein corona. ACS Appl Mater Interfaces (2014) 0.76
Size-dependent cellular toxicity and uptake of commercial colloidal gold nanoparticles in DU-145 cells. Cancer Nanotechnol (2013) 0.76
The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency. J Control Release (2013) 0.76
Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles. Int J Nanomedicine (2016) 0.76
Negatively charged metal oxide nanoparticles interact with the 20S proteasome and differentially modulate its biologic functional effects. ACS Nano (2013) 0.76
Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona. PLoS One (2017) 0.76
Toward a molecular understanding of nanoparticle-protein interactions. Biophys Rev (2012) 0.76
Microfluidic on-chip capture-cycloaddition reaction to reversibly immobilize small molecules or multi-component structures for biosensor applications. J Vis Exp (2013) 0.75
Characterisation of the protein corona using tunable resistive pulse sensing: determining the change and distribution of a particle's surface charge. Anal Bioanal Chem (2016) 0.75
Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application. Int J Nanomedicine (2016) 0.75
The Gold Nanorod-Biology Interface: From Proteins to Cells to Tissue. Curr Phys Chem (2013) 0.75
Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles. Nanomaterials (Basel) (2016) 0.75
High content analysis at single cell level identifies different cellular responses dependent on nanomaterial concentrations. Sci Rep (2015) 0.75
Enhanced detection with spectral imaging fluorescence microscopy reveals tissue- and cell-type-specific compartmentalization of surface-modified polystyrene nanoparticles. J Nanobiotechnology (2016) 0.75
Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials. Nat Protoc (2017) 0.75
Recovery of Drug Delivery Nanoparticles from Human Plasma Using an Electrokinetic Platform Technology. Small (2015) 0.75
Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles. Nanomaterials (Basel) (2015) 0.75
The fate of a designed protein corona on nanoparticles in vitro and in vivo. Beilstein J Nanotechnol (2015) 0.75
Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models. Tissue Barriers (2016) 0.75
The nanoparticle protein corona formed in human blood or human blood fractions. PLoS One (2017) 0.75
Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition. Int J Nanomedicine (2015) 0.75
Air-liquid interface exposure to aerosols of poorly soluble nanomaterials induces different biological activation levels compared to exposure to suspensions. Part Fibre Toxicol (2016) 0.75
Protein corona: a new approach for nanomedicine design. Int J Nanomedicine (2017) 0.75
Biomedical applications of nanotechnology. Biophys Rev (2017) 0.75
Interaction of gold nanoparticles with proteins and cells. Sci Technol Adv Mater (2015) 0.75
Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state. Sci Rep (2017) 0.75
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
The La protein. Annu Rev Biochem (2001) 3.32
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci (2007) 2.22
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets. Blood (2012) 1.59
Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol (2007) 1.59
The protein expression of Streptococcus pyogenes is significantly influenced by human plasma. J Proteome Res (2005) 1.55
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) (2011) 1.43
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release (2012) 1.41
Exposure assessment: recommendations for nanotechnology-based pesticides. Int J Occup Environ Health (2011) 1.39
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One (2010) 1.34
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nat Methods (2005) 1.32
A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci U S A (2003) 1.31
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res (2008) 1.28
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett (2008) 1.25
Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small (2011) 1.25
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol (2009) 1.20
Nanotoxicology: nanoparticles reconstruct lipids. Nat Nanotechnol (2009) 1.19
Dynamic force sensing of filamin revealed in single-molecule experiments. Proc Natl Acad Sci U S A (2012) 1.17
Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study. Proteomics (2004) 1.14
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci (2010) 1.14
Nanopesticides: guiding principles for regulatory evaluation of environmental risks. J Agric Food Chem (2014) 1.12
Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine (Lond) (2013) 1.11
Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials (2006) 1.10
Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J (2007) 1.09
Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood (2002) 1.09
Purification of biotinylated proteins on streptavidin resin: a protocol for quantitative elution. Proteomics (2004) 1.08
A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics (2006) 1.03
In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol (2009) 1.02
Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano (2015) 1.01
Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale (2013) 1.00
Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology (2011) 0.97
Structural changes in apolipoproteins bound to nanoparticles. Langmuir (2011) 0.96
Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping. Proteomics (2005) 0.95
Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology (2012) 0.94
Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology (2010) 0.93
Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology (2010) 0.91
Ultrafast folding kinetics and cooperativity of villin headpiece in single-molecule force spectroscopy. Proc Natl Acad Sci U S A (2013) 0.91
The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol (2008) 0.91
Elution of labile fluorescent dye from nanoparticles during biological use. PLoS One (2011) 0.90
Proteomic profiling of the human T-cell nucleolus. Mol Immunol (2011) 0.88
Redox sensitive cysteine residues in calbindin D28k are structurally and functionally important. Biochemistry (2005) 0.87
Phase behavior of aqueous polyion-surfactant ion complex salts: effects of polyion charge density. J Phys Chem B (2007) 0.87
Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus. PLoS One (2012) 0.87
Diagnostic and therapeutic applications of recombinant antibodies: targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis. Curr Pharm Des (2004) 0.87
Deamidation and disulfide bridge formation in human calbindin D28k with effects on calcium binding. Protein Sci (2005) 0.86
A comparison of different biotinylation reagents, tryptic digestion procedures, and mass spectrometric techniques for 2-D peptide mapping of membrane proteins. Proteomics (2005) 0.86
Integrated protein array screening and high throughput validation of 70 novel neural calmodulin-binding proteins. Mol Cell Proteomics (2010) 0.86
Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale (2013) 0.86
Modulation of gene expression by extracellular pH variations in human fibroblasts: a transcriptomic and proteomic study. Proteomics (2003) 0.85
Effect of natural organic matter on cerium dioxide nanoparticles settling in model fresh water. Chemosphere (2010) 0.85
Intracellular localisation, geno- and cytotoxic response of polyN-isopropylacrylamide (PNIPAM) nanoparticles to human keratinocyte (HaCaT) and colon cells (SW 480). Toxicol Lett (2010) 0.85
Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. Eur J Pharm Biopharm (2011) 0.85
The presence of outer arm fucose residues on the N-glycans of tissue inhibitor of metalloproteinases-1 reduces its activity. J Proteome Res (2013) 0.84
Formation and characterization of the nanoparticle-protein corona. Methods Mol Biol (2013) 0.84
Centrifugal drip is an accessible source for protein indicators of pork ageing and water-holding capacity. Meat Sci (2010) 0.84
Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening. Nanomedicine (2012) 0.84
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study. Cancer Immunol Immunother (2015) 0.83
Characterization of human melanoma cell lines and melanocytes by proteome analysis. Cell Cycle (2011) 0.83
Proteomic characterization of histotroph during the preimplantation phase of the estrous cycle in cattle. J Proteome Res (2012) 0.83
Setagin and secretagogin-R22: Posttranscriptional modification products of the secretagogin gene. Biochem Biophys Res Commun (2005) 0.83
Altered behavior, physiology, and metabolism in fish exposed to polystyrene nanoparticles. Environ Sci Technol (2014) 0.83
Exploring the glycosylation of serum CA125. Int J Mol Sci (2013) 0.82
Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution. ACS Chem Neurosci (2013) 0.82
Beta-thalassemia major and its effect on amino acid metabolism and growth in patients in the United Arab Emirates. Clin Chim Acta (2005) 0.82
Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy. Cancer Immunol Immunother (2014) 0.81
Polystyrene nanoparticles affecting blood coagulation. Nanomedicine (2011) 0.81
Is the toxic potential of nanosilver dependent on its size? Part Fibre Toxicol (2014) 0.81
Differentiating germinal center-derived lymphomas through their cellular microenvironment. Am J Hematol (2009) 0.81
Molecular basis of cell-biomaterial interaction: insights gained from transcriptomic and proteomic studies. Biomaterials (2006) 0.80
The protein corona mediates the impact of nanomaterials and slows amyloid beta fibrillation. Chembiochem (2013) 0.80
Radretumab radioimmunotherapy in patients with brain metastasis: a 124I-L19SIP dosimetric PET study. Cancer Immunol Res (2013) 0.80
Crystallin distribution patterns in concentric layers from toad eye lenses. Proteomics (2009) 0.80
The need for in situ characterisation in nanosafety assessment: funded transnational access via the QNano research infrastructure. Nanotoxicology (2012) 0.79
Cytotoxic effects in 3T3-L1 mouse and WI-38 human fibroblasts following 72 hour and 7 day exposures to commercial silica nanoparticles. Toxicol Appl Pharmacol (2012) 0.79
Size-dependent effects of nanoparticles on enzymes in the blood coagulation cascade. Nano Lett (2014) 0.79